Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1990 Jul;74(7):413–416. doi: 10.1136/bjo.74.7.413

Comparison of the effect of acetazolamide tablets and sustets on diurnal intraocular pressure in patients with chronic simple glaucoma.

P W Joyce 1, K B Mills 1
PMCID: PMC1042151  PMID: 2198932

Abstract

Twenty patients with primary open-angle glaucoma uncontrolled on single topical therapy completed a double dummy crossover study to compare acetazolamide tablets with a sustained release formulation (Sustet). The two preparations were equally effective, but no direct relationship was found between the intraocular pressure and the plasma concentration of acetazolamide. No difference between the formulations was found in the frequency or severity of side effects.

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKER B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. Am J Ophthalmol. 1954 Jan;37(1):13–15. doi: 10.1016/0002-9394(54)92027-9. [DOI] [PubMed] [Google Scholar]
  2. BECKER B., MIDDLETON W. H. Long-term acetazoleamide (diamox) administration in therapy of glaucomas. AMA Arch Ophthalmol. 1955 Aug;54(2):187–192. doi: 10.1001/archopht.1955.00930020191004. [DOI] [PubMed] [Google Scholar]
  3. Berson F. G., Epstein D. L., Grant W. M., Hutchinson B. T., Dobbs P. C. Acetazolamide dosage forms in the treatment of glaucoma. Arch Ophthalmol. 1980 Jun;98(6):1051–1054. doi: 10.1001/archopht.1980.01020031041005. [DOI] [PubMed] [Google Scholar]
  4. DE CARVALHO C. A., LAWRENCE C., STONE H. H. Acetazolamide (diamox) therapy in chronic glaucoma; a three-year follow-up study. AMA Arch Ophthalmol. 1958 Jun;59(6):840–849. doi: 10.1001/archopht.1958.00940070054005. [DOI] [PubMed] [Google Scholar]
  5. Drance S. M., Carr F. EFFECT OF SUSTAINED-RELEASE DIAMOX ON THE INTRA-OCULAR PRESSURE IN MAN. Br J Ophthalmol. 1961 Oct;45(10):695–698. doi: 10.1136/bjo.45.10.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friedland B. R., Mallonee J., Anderson D. R. Short-term dose response characteristics of acetazolamide in man. Arch Ophthalmol. 1977 Oct;95(10):1809–1812. doi: 10.1001/archopht.1977.04450100111014. [DOI] [PubMed] [Google Scholar]
  7. Hass I., Drance S. M. Comparison between pilocarpine and timolol on diurnal pressures in open-angle glaucoma. Arch Ophthalmol. 1980 Mar;98(3):480–481. doi: 10.1001/archopht.1980.01020030476006. [DOI] [PubMed] [Google Scholar]
  8. KUPFER C., LAWRENCE C., LINNER E. Long-term administration of acetazoleamide (diamox) in the treatment of glaucoma. Am J Ophthalmol. 1955 Nov;40(5 Pt 1):673–680. doi: 10.1016/0002-9394(55)91494-x. [DOI] [PubMed] [Google Scholar]
  9. Lichter P. R., Musch D. C., Medzihradsky F., Standardi C. L. Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma. Am J Ophthalmol. 1989 Jan 15;107(1):11–17. doi: 10.1016/0002-9394(89)90807-6. [DOI] [PubMed] [Google Scholar]
  10. Lichter P. R., Newman L. P., Wheeler N. C., Beall O. V. Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol. 1978 Apr;85(4):495–502. doi: 10.1016/s0002-9394(14)75247-x. [DOI] [PubMed] [Google Scholar]
  11. MESTRE C., GALIN M. A., MCLEAN J. M. EVALUATION OF SUSTAINED-RELEASE ACETAZOLAMIDE. Br J Ophthalmol. 1963 Jan;47:31–35. doi: 10.1136/bjo.47.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wistrand P. J. The use of carbonic anhydrase inhibitors in ophthalmology and clinical medicine. Ann N Y Acad Sci. 1984;429:609–619. doi: 10.1111/j.1749-6632.1984.tb12398.x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES